These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 5363860)

  • 1. [Developing a clinical classification of systemic scleroderma].
    Guseva NG
    Vopr Revm; 1969; 9(2):14-8. PubMed ID: 5363860
    [No Abstract]   [Full Text] [Related]  

  • 2. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis.
    LeRoy EC; Black C; Fleischmajer R; Jablonska S; Krieg T; Medsger TA; Rowell N; Wollheim F
    J Rheumatol; 1988 Feb; 15(2):202-5. PubMed ID: 3361530
    [No Abstract]   [Full Text] [Related]  

  • 3. [The evolution of the concepts of systemic scleroderma].
    Guseva NG
    Ter Arkh; 1995; 67(5):50-3. PubMed ID: 7638781
    [No Abstract]   [Full Text] [Related]  

  • 4. Preliminary criteria for the classification of systemic sclerosis (scleroderma).
    Bull Rheum Dis; 1981; 31(1):1-6. PubMed ID: 7459513
    [No Abstract]   [Full Text] [Related]  

  • 5. Classification in systemic sclerosis.
    Johnson SR; Laxer RM
    J Rheumatol; 2006 May; 33(5):840-1. PubMed ID: 16652415
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinico-immunological characteristics of the course of systemic scleroderma].
    Musaev SK; Speranskiĭ AI
    Ter Arkh; 1984; 56(5):42-5. PubMed ID: 6611599
    [No Abstract]   [Full Text] [Related]  

  • 7. The development of systemic sclerosis (scleroderma) following augmentation mammoplasty.
    Appleton BE; Lee P
    J Rheumatol; 1993 Jun; 20(6):1052-4. PubMed ID: 8350312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Medical disability expertise in systemic scleroderma].
    Shabel'nik VI; Tsyban' ME; Filiuk VF; Eliseĭkina LV; Lanchuk SG
    Revmatologiia (Mosk); 1988; (2):23-6. PubMed ID: 3051271
    [No Abstract]   [Full Text] [Related]  

  • 9. [Some clinical variants of scleroderma].
    Braĭtsev AV; Marzeeva GI
    Vestn Dermatol Venerol; 1973 Aug; 47(8):19-24. PubMed ID: 4767948
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical evaluation of the determination of blood serum and urinary glycosaminoglycans in systemic scleroderma].
    Fuzaĭlov OR; Astakhova TA; Guseva NG
    Ter Arkh; 1984; 56(5):45-9. PubMed ID: 6463886
    [No Abstract]   [Full Text] [Related]  

  • 11. [Characteristics of the clinical course of systemic scleroderma].
    Iashchenko OB
    Vrach Delo; 1984 Sep; (9):88-92. PubMed ID: 6506654
    [No Abstract]   [Full Text] [Related]  

  • 12. [Role of tryptophan metabolism in the pathogenesis of systemic scleroderma and pseudosclerodermic conditions].
    Stachow A
    Przegl Dermatol; 1979; 66(6):727-9. PubMed ID: 534291
    [No Abstract]   [Full Text] [Related]  

  • 13. [Collagen disease posing a difficult classification problem: scleroderma associated with Gougerot-Sjögren's syndrome].
    Bouvier J; Michel PH; Cretin J
    Bull Soc Fr Dermatol Syphiligr; 1968; 75(2):245-7. PubMed ID: 5677915
    [No Abstract]   [Full Text] [Related]  

  • 14. [Characteristics of clinical symptoms and course of systemic scleroderma depending on sex and age of onset].
    Volkov AV; Starovoĭtova MN; Guseva NG
    Ter Arkh; 2004; 76(5):7-11. PubMed ID: 15230123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Scleroderma. Etiopathogenetic and therapeutic considerations].
    Carlesimo OA; Nini G; Santucci B
    Minerva Dermatol; 1967 Jan; 42(1):1-11. PubMed ID: 5596505
    [No Abstract]   [Full Text] [Related]  

  • 16. [Role of blood vessels in the pathogenesis of diffuse scleroderma].
    Kamiński A
    Przegl Dermatol; 1974; 61(5):639-47. PubMed ID: 4278576
    [No Abstract]   [Full Text] [Related]  

  • 17. A proposal of criteria for the classification of systemic sclerosis.
    Nadashkevich O; Davis P; Fritzler MJ
    Med Sci Monit; 2004 Nov; 10(11):CR615-21. PubMed ID: 15507853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Transformation of scleroatrophic lichen into systemic scleroderma].
    Grebennikov VA; Chalimova RA
    Vestn Dermatol Venerol; 1983 Apr; (4):60-3. PubMed ID: 6882513
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical significance of circulating immune complexes in systemic scleroderma].
    Musaev SK; Speranskiĭ AI
    Revmatologiia (Mosk); 1984; (2):48-50. PubMed ID: 6382544
    [No Abstract]   [Full Text] [Related]  

  • 20. [Scleroderma in children].
    Beaudoing A; Bost M; Pont J; Dieterlen M
    Pediatrie; 1971; 26(5):529-46. PubMed ID: 5565710
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.